DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Geron Corp (NASDAQ: GERN)

3.24 0.18 (5.88%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GERN $3.24 5.88%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.06
Previous Close $3.06
Daily Range $3.05 - $3.24
52-Week Range $1.39 - $5.92
Market Cap $509.4M
P/E Ratio -12.24
Dividend (Yield) $0.00 (0.0%)
Volume 1,493,225
Average Daily Volume 6,543,171
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/

News & Commentary Rss Feed

Why Geron Corporation Stock Surged 65% in November

Geron delivers a trio of good news to its shareholders, causing its stock to rocket higher in November. But, can the good times last?

Geron Enters 2015 On A More Assured Note

Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape

4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog

Today's Dead Cat Bounce Stock: Geron (GERN)

Why Geron Corporation (GERN) Stock Might be a Great Pick - Tale of the Tape

Why Geron Corporation (GERN) Stock Might be a Great Pick - Tale of the Tape

Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape

Health Care Sector Update for 12/05/2014: GERN,ATOS,PBMD

BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotec

BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution?

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015

Biotech stocks have been crushing the broader markets in recent years. Here are three biotech companies poised to continue this trend in 2015.

See More GERN News...

GERN's Top Competitors

GERN $3.24 (5.88%)
Current stock: GERN
AMGN $163.46 (1.74%)
Current stock: AMGN
GILD $93.79 (2.74%)
Current stock: GILD
BIIB $342.40 (0.44%)
Current stock: BIIB